In contrast, CS1 expression on CD3+ T cells, measured by median fluorescence intensity ratio (MFIR), was significantly reduced at diagnosis (day 0, 1BD) in both very high-risk (1.76) and high-risk (2.47) ALL patients compared to healthy (3.89) individuals (Figure 2K). Here, SLAMF7 is linked to acute lymphoblastic leukemia.